Bayer seeks to block Nexavar generic at Delaware court

03-02-2015

Bayer seeks to block Nexavar generic at Delaware court

360b / Shutterstock.com

Bayer and Onyx Pharmaceuticals have sued generic drug maker Mylan in an attempt to stop it from developing a version of liver cancer drug Nexavar (sorafenib tosylate).


Bayer, Onyx Pharmaceuticals, Mylan, Nexavar, US District Court for the District of Delaware, patent

LSIPR